Try our mobile app

Switch to company model in "Rising Stars" logic    *

General information

Country: UNITED STATES

Sector: Medical Devices

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. The company offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. It offers orthopedic surgery products under Hall, CONMED Linvatec, Concept, and Shutt brands. The company also offers general surgery product in the areas of advanced surgical comprising clinical insufflation system; electrosurgical products; and endomechanical products comprising instruments, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors. In addition, it offers endoscopic technologies offering, including diagnostic and therapeutic products for use in gastroenterology procedures; cardiology and critical care products cover a line of vital signs, cardiac monitoring, and patient care products, including ECG electrodes and accessories, cardiac defibrillation and pa...
Website: conmed.com


  • Pretty weak financial results growth rate 4.4% (average between last period year over year growth for revenue and EBITDA), there is slowdown compared to average historical growth rates (16.6%)
  • Dividend yield for the last twelve months 2.0%
  • Free cash flow yield 0.0% (LTM)
  • Share price is 5.1% higher than minimum and 70.0% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (5.5x vs 30.0x)
  • Fundamental value created in LTM (estimate)

Key Financials (Download financials)

Ticker: CNMD
Share price, USD:  (0.0%)40.98
year average price 50.27  


year start price 63.15 2025-02-14

max close price 63.15 2025-02-14

min close price 38.99 2025-12-09

current price 40.98 2026-02-13
Common stocks: 30 856 000

Dividend Yield:  2.0%
EV / LTM EBITDA: 5.5x
EV / EBITDA annualized: 4.5x
Last revenue growth (y/y):  +5.8%
Last growth of EBITDA (y/y):  +2.9%
Historical revenue growth:  +9.4%
Historical growth of EBITDA:  +23.9%
EV / Sales: 1.0x
Margin (EBITDA LTM / Revenue): 17.6%

Target EV / EBITDA (hist percentile): 30.0x
Express share price potential:
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 1 264
Net Debt ($m): 0
EV (Enterprise Value): 1 264
EBITDA LTM (млн $): 230
EV / LTM EBITDA: 5.5x
Price to Book: 1.3x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2026-01-28zacks.com

Compared to Estimates, Conmed (CNMD) Q4 Earnings: A Look at Key Metrics

2026-01-28seekingalpha.com

CONMED Corporation (CNMD) Q4 2025 Earnings Call Transcript

2026-01-12seekingalpha.com

CONMED Corporation (CNMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2025-12-31zacks.com

Here's Why You Should Retain CONMED Stock in Your Portfolio Now

2025-12-30zacks.com

Why Conmed (CNMD) is a Top Value Stock for the Long-Term

2025-12-11zacks.com

Here's Why Conmed (CNMD) is a Strong Value Stock

2025-12-08zacks.com

CONMED Stock Falls as It Strategically Exits Gastroenterology Portfolio

2025-12-05zacks.com

Why Is Conmed (CNMD) Up 0.1% Since Last Earnings Report?

2025-12-04zacks.com

Here's Why You Should Add CONMED Stock to Your Portfolio Now

2025-12-04zacks.com

5 Value Stocks With Exciting EV-to-EBITDA Ratios to Scoop Up
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q4 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-12-31 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol CNMD CNMD CNMD CNMD CNMD CNMD CNMD CNMD CNMD CNMD CNMD CNMD CNMD CNMD CNMD
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 816 956 816 956 816 956 816 956 816 956 816 956 816 956 816 956 816 956 816 956 816 956 816 956 816 956 816 956 816 956
filingDate 2025-12-31 2025-02-18 2024-02-28 2023-02-21 2022-02-22 2021-02-22
acceptedDate 2025-12-30 19:00:00 2025-11-06 12:39:25 2025-07-31 09:25:54 2025-02-18 10:15:11 2024-10-31 08:52:17 2024-08-01 10:40:50 2024-04-25 09:52:41 2024-02-28 08:57:59 2023-10-26 09:22:04 2023-07-27 11:06:48 2023-04-27 11:22:43 2023-02-21 10:49:19 2022-10-27 10:40:22 2022-02-22 08:37:45 2021-02-22 13:28:50
fiscalYear 2025 2024 2023 2022 2021 2020
period FY Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 1 375M 338M 342M 1 307M 317M 331M 312M 1 245M 305M 318M 295M 1 045M 275M 1 011M 862M
costOfRevenue 634M 172M 154M 574M 138M 158M 150M 568M 137M 147M 140M 474M 123M 443M 402M
grossProfit 741M 166M 188M 733M 179M 173M 162M 676M 168M 171M 155M 571M 152M 568M 460M
researchAndDevelopmentExpenses 56M 14M 14M 54M 14M 14M 14M 53M 12M 14M 13M 47M 13M 44M 40M
generalAndAdministrativeExpenses 0 0 121M 0 0 0 0 0 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 17M 0 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 555M 140M 138M 478M 100M 122M 106M 503M 125M 130M 130M 454M 115M 415M 374M
otherExpenses 0 0 -2M 0 0 -9M 0 0 0 0 0 0 0 0 0
operatingExpenses 610M 154M 150M 533M 113M 136M 120M 556M 138M 143M 143M 501M 127M 458M 414M
costAndExpenses 1 245M 326M 304M 1 107M 251M 294M 269M 1 124M 274M 290M 283M 975M 251M 901M 816M
netInterestIncome -31M -37M -40M -29M -35M -44M
interestIncome 0 0 0 0 0 0 0 0 10M 0 0 0 0 0 0
interestExpense 31M 8M 8M 37M 9M 10M 10M 40M 10M 10M 10M 29M 9M 35M 44M
depreciationAndAmortization 74M 19M 19M 72M 18M 13M 13M 72M 18M 18M 18M 50M 18M 71M 73M
ebitda 177M 30M 56M 272M 84M 47M 55M 192M 30M 27M 13M 8M 42M 179M 118M
ebit 103M 200M 121M -42M 109M 46M
nonOperatingIncomeExcludingInterest 28M 0 0 112M 1M 355 000
operatingIncome 130M 12M 38M 200M 66M 37M 42M 121M 30M 27M -5M 70M 24M 110M 46M
totalOtherIncomeExpensesNet -59M -8M -8M -37M -9M -10M -17M -40M -10M -10M 8M -141M -9M -37M -44M
incomeBeforeTax 71M 4M 30M 163M 56M 38M 25M 81M 20M 17M 2M -71M 16M 73M 2M
incomeTaxExpense 24M 1M 8M 31M 7M 8M 6M 16M 4M 4M 625 000 10M -30M 11M -8M
netIncomeFromContinuingOperations 47M 132M 64M -81M 63M 10M
netIncomeFromDiscontinuedOperations 0 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0 0
netIncome 47M 3M 21M 132M 49M 30M 20M 64M 16M 14M 2M -81M 46M 63M 10M
netIncomeDeductions 0 0 0 0 0 0
bottomLineNetIncome 47M 132M 64M -81M 63M 10M
eps 1.52 0.09 0.69 4.29 1.59 0.97 0.64 2.1 0.52 0.45 0.06 -2.68 1.51 2.14 0.33
epsDiluted 1.51 4.26 2.04 -2.68 1.94 0.32
weightedAverageShsOut 31M 31M 31M 31M 31M 31M 31M 31M 31M 31M 31M 30M 30M 29M 29M
weightedAverageShsOutDil 31M 31M 31M 31M 31M 31M 31M 32M 32M 32M 31M 30M 31M 32M 29M
fillingDate 2025-11-06 2025-07-31 2024-10-31 2024-08-01 2024-04-25 2023-10-26 2023-07-27 2023-04-27 2022-10-27
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
grossProfitRatio 0.492 0.55 0.565 0.524 0.52 0.552 0.537 0.526 0.551
ebitdaratio 0.09 0.164 0.264 0.151 0.176 0.099 0.086 0.043 0.152
operatingIncomeRatio 0.035 0.111 0.207 0.113 0.136 0.099 0.086 -0.018 0.088
incomeBeforeTaxRatio 0.013 0.087 0.178 0.113 0.082 0.067 0.055 0.008 0.057
netIncomeRatio 0.008 0.063 0.155 0.091 0.063 0.052 0.043 0.006 0.168
epsdiluted 0.09 0.69 1.57 0.96 0.63 0.5 0.43 0.058 1.48
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol CNMD CNMD CNMD CNMD CNMD CNMD CNMD CNMD CNMD CNMD CNMD CNMD CNMD CNMD
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 816 956 816 956 816 956 816 956 816 956 816 956 816 956 816 956 816 956 816 956 816 956 816 956 816 956 816 956
fillingDate 2025-11-06 2025-07-31 2024-10-31 2024-08-01 2024-04-25 2023-10-26 2023-07-27 2023-04-27 2022-10-27
acceptedDate 2025-11-06 12:39:25 2025-07-31 09:25:54 2025-02-18 10:15:11 2024-10-31 08:52:17 2024-08-01 10:40:50 2024-04-25 09:52:41 2024-02-28 08:57:59 2023-10-26 09:22:04 2023-07-27 11:06:48 2023-04-27 11:22:43 2023-02-21 10:49:19 2022-10-27 10:40:22 2022-02-22 08:37:45 2021-02-22 13:28:50
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 39M 34M 24M 38M 29M 34M 24M 31M 28M 26M 29M 33M 21M 27M
shortTermInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
cashAndShortTermInvestments 39M 34M 24M 38M 29M 34M 24M 31M 28M 26M 29M 33M 21M 27M
netReceivables 225M 234M 238M 231M 239M 241M 242M 230M 229M 213M 191M 197M 184M 177M
inventory 364M 362M 347M 343M 322M 322M 318M 326M 327M 335M 332M 305M 232M 195M
otherCurrentAssets 34M 27M 31M 29M 33M 38M 31M 39M 31M 35M 29M 39M 0 0
totalCurrentAssets 662M 658M 640M 641M 624M 636M 616M 626M 616M 610M 581M 574M 460M 417M
propertyPlantEquipmentNet 112M 117M 116M 117M 117M 118M 121M 120M 117M 115M 116M 114M 109M 111M
goodwill 807M 807M 805M 807M 806M 806M 807M 815M 816M 815M 815M 814M 618M 618M
intangibleAssets 593M 602M 618M 626M 633M 641M 649M 657M 666M 674M 682M 689M 471M 502M
goodwillAndIntangibleAssets 1 400M 1 409M 1 423M 1 432M 1 439M 1 448M 1 456M 1 472M 1 481M 1 489M 1 497M 1 504M 1 089M 1 120M
longTermInvestments 0 0 0 0 132 000 6M 0 -67M -66M 0 0 0 0 0
taxAssets 0 0 11M 66M 65M 64M 11M 67M 66M 66M 10M 0 10M 7M
otherNonCurrentAssets 148M 145M 116M 59M 40M 38M 96M 107M 109M 40M 94M 100M 99M 97M
totalNonCurrentAssets 1 660M 1 671M 1 666M 1 675M 1 662M 1 674M 1 684M 1 700M 1 707M 1 710M 1 716M 1 718M 1 306M 1 335M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 2 322M 2 328M 2 306M 2 316M 2 286M 2 309M 2 300M 2 326M 2 323M 2 320M 2 298M 2 292M 1 766M 1 752M
accountPayables 107M 101M 102M 105M 101M 102M 88M 82M 79M 77M 73M 74M 58M 53M
shortTermDebt 746 000 714 000 715 000 717 000 716 000 692 000 0 71M 70M 70M 70M 237 000 12M 18M
taxPayables 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredRevenue 0 0 0 0 -1 0 0 60M 55M 0 0 0 0 0
otherCurrentLiabilities 207M 193M 175M 177M 164M 189M 144M 163M 150M 174M 153M 134M 126M 111M
totalCurrentLiabilities 315M 295M 278M 282M 266M 291M 311M 376M 353M 321M 297M 209M 197M 190M
longTermDebt 853M 881M 905M 940M 967M 990M 971M 942M 971M 995M 985M 1 036M 672M 735M
deferredRevenueNonCurrent 0 0 0 0 0 1 0 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 75M 70M 74M 66M 65M 64M 61M 67M 66M 66M 67M 113M 69M 58M
otherNonCurrentLiabilities 72M 80M 86M 95M 105M 109M 111M 144M 152M 186M 204M 1 293M 43M 44M
totalNonCurrentLiabilities 1 000M 1 031M 1 065M 1 101M 1 137M 1 163M 1 155M 1 153M 1 189M 1 247M 1 255M 1 367M 784M 852M
otherLiabilities 0 0 0 0 1 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 0 0 0 0 2M 2M 20M 3M 0 0 0 0 0 23M
totalLiabilities 1 314M 1 326M 1 344M 1 383M 1 404M 1 455M 1 466M 1 529M 1 543M 1 568M 1 552M 1 576M 981M 1 043M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 313 000 313 000 313 000 313 000 313 000 313 000 313 000 313 000 313 000 313 000 313 000 313 000 313 000 313 000
retainedEarnings 572M 575M 560M 533M 490M 466M 453M 426M 416M 408M 413M 392M 497M 457M
accumulatedOtherComprehensiveIncomeLoss -49M -53M -59M -55M -54M -50M -50M -54M -53M -55M -58M -60M -54M -64M
othertotalStockholdersEquity 485M 480M 455M 446M 438M 424M 417M 399M 384M
totalStockholdersEquity 1 008M 1 003M 963M 933M 882M 855M 834M 796M 780M 752M 746M 716M 785M 709M
totalEquity 1 008M 1 003M 963M 933M 882M 855M 834M 796M 780M 752M 746M 716M 785M 709M
totalLiabilitiesAndStockholdersEquity 2 322M 2 328M 2 316M 2 286M 2 309M 2 326M 2 323M 2 320M 2 292M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 2 322M 2 328M 2 306M 2 316M 2 286M 2 309M 2 300M 2 326M 2 323M 2 320M 2 298M 2 292M 1 766M 1 752M
totalInvestments 0 0 0 -66M 132 000 6M 0 -67M -66M 0 0 0 0 0
totalDebt 854M 882M 906M 941M 966M 991M 991M 1 013M 1 041M 1 065M 1 055M 1 037M 685M 776M
netDebt 815M 848M 881M 902M 937M 957M 967M 982M 1 013M 1 038M 1 026M 1 003M 664M 749M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-18 2024-02-28 2023-02-21 2022-02-22 2021-02-22
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 238M 242M 191M 184M 177M
otherReceivables 0 0 0 0 0
prepaids 0 0 0 24M 17M
totalPayables 102M 88M 73M 58M 53M
otherPayables 0 0 0 0 0
accruedExpenses 0 70M 0 0 0
capitalLeaseObligationsCurrent 0 8M 0 0 8M
capitalLeaseObligationsNonCurrent 0 12M 0 0 15M
treasuryStock -16M -15M -23M -54M -68M
additionalPaidInCapital 477M 447M 413M 397M 383M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol CNMD CNMD CNMD CNMD CNMD CNMD CNMD CNMD CNMD CNMD CNMD CNMD CNMD CNMD
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 816 956 816 956 816 956 816 956 816 956 816 956 816 956 816 956 816 956 816 956 816 956 816 956 816 956 816 956
fillingDate 2025-11-06 2025-07-31 2024-10-31 2024-08-01 2024-04-25 2023-10-26 2023-07-27 2023-04-27 2022-10-27
acceptedDate 2025-11-06 12:39:25 2025-07-31 09:25:54 2025-02-18 10:15:11 2024-10-31 08:52:17 2024-08-01 10:40:50 2024-04-25 09:52:41 2024-02-28 08:57:59 2023-10-26 09:22:04 2023-07-27 11:06:48 2023-04-27 11:22:43 2023-02-21 10:49:19 2022-10-27 10:40:22 2022-02-22 08:37:45 2021-02-22 13:28:50
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome 3M 21M 132M 49M 30M 20M 64M 16M 14M 2M -81M 46M 63M 10M
depreciationAndAmortization 19M 19M 51M 13M 13M 13M 51M 18M 18M 18M 70M 18M 71M 73M
deferredIncomeTax 4M 2M 12M 3M 1M 2M 700 000 -284 000 533 000 -1M -6M -32M 3M -14M
stockBasedCompensation 5M 5M 26M 6M 7M 6M 24M 6M 6M 6M 22M 6M 16M 13M
changeInWorkingCapital 21M -17M -40M 17M -5M -12M -40M 2M -13M -34M -91M -13M -56M -30M
accountsReceivables 9M -8M -2M 11M 914 000 -908 000 -47M -3M -15M -21M -5M 2M -9M 14M
inventory -2M -6M -32M -19M -746 000 -5M 14M 818 000 7M -3M -79M -17M -38M -30M
accountsPayables 5M 6M 15M 2M 301 000 13M 15M 4M 2M 3M 13M 751 000 5M -3M
otherWorkingCapital 9M -10M -21M 23M -6M -19M -21M 152 000 -8M -13M -20M 973 000 -14M -10M
otherNonCashItems 3M -48 000 -15M -36M 30M 25M 24M 5M 869 000 6M 119M 1M 15M 13M
netCashProvidedByOperatingActivities 54M 29M 167M 51M 43M 29M 125M 46M 27M -4M 33M 26M 112M 65M
investmentsInPropertyPlantAndEquipment -5M -6M -13M -3M -4M -2M -19M -5M -5M -4M -22M -7M -15M -13M
acquisitionsNet 0 0 0 0 0 0 0 0 0 0 -228M -85M 0 -4M
purchasesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
salesMaturitiesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherInvestingActivites 0 0 0 0 0 0 -1 000 000 0 0
netCashUsedForInvestingActivites -5M -6M -3M -4M -2M -5M -6M -4M -91M
debtRepayment -29M -11M -26M 927 999 -11M -213M -183M -164M -92M
commonStockIssued 0 0 0 0 0 0 0 0 0
commonStockRepurchased 0 0 0 0 0 0 0 0 0 0 -72M 0 0 0
dividendsPaid -6M -6M -6M -6M -6M -6M -6M -6M -6M
otherFinancingActivites -8M -9M -7M -39M 67 000 182M 169M 175M 145M
netCashUsedProvidedByFinancingActivities -44M -27M -39M -44M -17M -37M -20M 5M 47M
effectOfForexChangesOnCash 20 000 2M -3M 645 000 -617 000 -513 000 470 000 -850 000 -3000 303 000 -741 000 -1M -2M 3M
netChangeInCash 5M -2M 163 000 10M -5M 10M -5M 3M 1M -2M 8M -20M -7M 2M
cashAtEndOfPeriod 39M 34M 24M 38M 29M 34M 24M 31M 28M 26M 29M 33M 21M 27M
cashAtBeginningOfPeriod 34M 35M 24M 29M 34M 24M 29M 28M 26M 29M 21M 53M 27M 26M
operatingCashFlow 54M 29M 167M 51M 43M 29M 125M 46M 27M -4M 33M 26M 112M 65M
capitalExpenditure -5M -6M -13M -3M -4M -2M -19M -5M -5M -4M -22M -7M -15M -13M
freeCashFlow 48M 23M 154M 48M 40M 27M 106M 41M 22M -8M 12M 19M 97M 52M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-18 2024-02-28 2023-02-21 2022-02-22 2021-02-22
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 0 -1 000 000 0 0 3M
netCashProvidedByInvestingActivities -13M -20M -250M -15M -14M
netDebtIssuance -72M -88M 362M -81M -29M
longTermNetDebtIssuance -72M -88M 362M -81M -26M
shortTermNetDebtIssuance 0 0 0 0 -3M
netStockIssuance 0 0 0 0 0
netCommonStockIssuance 0 0 0 0 0
commonStockIssuance 0 0 72M 0 0
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid -25M -25M -24M -23M -23M
commonDividendsPaid -25M -25M -24M -23M -23M
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -54M 2M -113M 3M 162 000
netCashProvidedByFinancingActivities -151M -110M 225M -102M -52M
incomeTaxesPaid 15M 20M 9M 9M 9M
interestPaid 33M 34M 26M 22M 30M

Earning call transcript

2025 q4
2026-01-28 ET (fiscal 2025 q4)
2025 q3
2025-11-05 ET (fiscal 2025 q3)
2025 q2
2025-07-30 ET (fiscal 2025 q2)
2025 q1
2025-04-30 ET (fiscal 2025 q1)
2024 q4
2025-02-05 ET (fiscal 2024 q4)
2024 q3
2024-10-30 ET (fiscal 2024 q3)
2024 q2
2024-07-31 ET (fiscal 2024 q2)
2024 q1
2024-04-25 ET (fiscal 2024 q1)
2023 q4
2024-01-31 ET (fiscal 2023 q4)
2023 q3
2023-10-25 ET (fiscal 2023 q3)
2023 q2
2023-07-26 ET (fiscal 2023 q2)
2023 q1
2023-04-26 ET (fiscal 2023 q1)
2022 q4
2023-02-02 ET (fiscal 2022 q4)
2022 q3
2022-10-26 ET (fiscal 2022 q3)
2022 q2
2022-07-27 ET (fiscal 2022 q2)
2022 q1
2022-05-08 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 8
2026-01-28 16:13 ET
CONMED Corporation published news for 2025 q4
SEC form 8
2026-01-28 16:13 ET
CONMED Corporation reported for 2025 q4
SEC form 8
2026-01-12 14:00 ET
CONMED Corporation published news for 2025 q4
SEC form 8
2026-01-12 14:00 ET
CONMED Corporation published news for 2025 q4
SEC form 8
2025-12-05 08:09 ET
CONMED Corporation published news for 2025 q3
SEC form 8
2025-12-05 08:09 ET
CONMED Corporation published news for 2025 q3
SEC form 10
2025-11-06 17:39 ET
CONMED Corporation reported for 2025 q3
SEC form 8
2025-11-05 16:15 ET
CONMED Corporation published news for 2025 q3
SEC form 8
2025-11-05 16:15 ET
CONMED Corporation reported for 2025 q3
SEC form 10
2025-07-31 13:25 ET
CONMED Corporation reported for 2025 q2
SEC form 8
2025-07-30 20:17 ET
CONMED Corporation published news for 2025 q2
SEC form 8
2025-07-30 20:17 ET
CONMED Corporation reported for 2025 q2
SEC form 10
2025-05-01 15:07 ET
CONMED Corporation reported for 2025 q1
SEC form 10
2025-05-01 00:00 ET
CONMED Corporation reported for 2025 q1
SEC form 8
2025-04-30 00:00 ET
CONMED Corporation published news for 2025 q1
SEC form 8
2025-04-30 00:00 ET
CONMED Corporation reported for 2025 q1
SEC form 10
2025-02-18 15:15 ET
CONMED Corporation published news for 2024 q4
SEC form 10
2025-02-18 00:00 ET
CONMED Corporation published news for 2024 q4
SEC form 8
2025-02-05 00:00 ET
CONMED Corporation published news for 2024 q4
SEC form 8
2025-02-05 00:00 ET
CONMED Corporation reported for 2024 q4
SEC form 10
2024-10-31 08:52 ET
CONMED Corporation reported for 2024 q3
SEC form 10
2024-10-31 00:00 ET
CONMED Corporation published news for 2024 q3
SEC form 8
2024-10-30 16:09 ET
CONMED Corporation published news for 2024 q3
SEC form 8
2024-10-30 16:09 ET
CONMED Corporation published news for 2024 q3
SEC form 8
2024-10-30 16:09 ET
CONMED Corporation published news for 2024 q3
SEC form 8
2024-10-30 16:09 ET
CONMED Corporation published news for 2024 q3
SEC form 8
2024-10-04 00:00 ET
CONMED Corporation published news for 2024 q3
SEC form 8
2024-10-04 00:00 ET
CONMED Corporation published news for 2024 q3
SEC form 10
2024-08-01 10:40 ET
CONMED Corporation published news for 2024 q2
SEC form 10
2024-08-01 00:00 ET
CONMED Corporation published news for 2024 q2
SEC form 8
2024-07-31 16:19 ET
CONMED Corporation published news for 2024 q2
SEC form 8
2024-07-31 16:19 ET
CONMED Corporation reported for 2024 q2
SEC form 10
2024-04-25 09:52 ET
CONMED Corporation published news for 2024 q1
SEC form 10
2024-04-25 00:00 ET
CONMED Corporation published news for 2024 q1
SEC form 8
2024-04-24 16:06 ET
CONMED Corporation published news for 2024 q1
SEC form 8
2024-04-24 16:06 ET
CONMED Corporation reported for 2024 q1
SEC form 10
2024-02-28 08:57 ET
CONMED Corporation published news for 2023 q4
SEC form 10
2024-02-28 00:00 ET
CONMED Corporation published news for 2023 q4
SEC form 8
2024-01-31 00:00 ET
CONMED Corporation published news for 2023 q4
SEC form 8
2024-01-31 00:00 ET
CONMED Corporation reported for 2023 q4
SEC form 10
2023-10-26 09:22 ET
CONMED Corporation published news for 2023 q3
SEC form 10
2023-10-26 00:00 ET
CONMED Corporation published news for 2023 q3
SEC form 8
2023-10-25 16:19 ET
CONMED Corporation reported for 2023 q3
SEC form 10
2023-07-27 11:06 ET
CONMED Corporation published news for 2023 q2
SEC form 10
2023-07-27 00:00 ET
CONMED Corporation published news for 2023 q2
SEC form 6
2023-07-26 16:17 ET
CONMED Corporation reported for 2023 q2
SEC form 8
2023-07-26 00:00 ET
CONMED Corporation published news for 2023 q2
SEC form 6
2023-06-15 15:06 ET
CONMED Corporation published news for 2023 q1
SEC form 10
2023-04-27 00:00 ET
CONMED Corporation published news for 2023 q1
SEC form 8
2023-04-26 00:00 ET
CONMED Corporation published news for 2023 q1
SEC form 6
2023-02-27 16:33 ET
CONMED Corporation published news for 2022 q4
SEC form 10
2023-02-21 10:49 ET
CONMED Corporation published news for 2022 q4
SEC form 10
2023-02-21 00:00 ET
CONMED Corporation reported for 2022 q4
SEC form 6
2023-02-02 16:30 ET
CONMED Corporation published news for 2022 q4
SEC form 8
2023-02-02 00:00 ET
CONMED Corporation reported for 2022 q4
SEC form 6
2022-12-27 16:40 ET
CONMED Corporation published news for 2022 q3
SEC form 6
2022-12-12 17:08 ET
CONMED Corporation published news for 2022 q3
SEC form 6
2022-12-06 21:34 ET
CONMED Corporation published news for 2022 q3
SEC form 6
2022-12-05 16:31 ET
CONMED Corporation published news for 2022 q3
SEC form 6
2022-11-15 07:05 ET
CONMED Corporation published news for 2022 q3
SEC form 10
2022-10-27 10:40 ET
CONMED Corporation published news for 2022 q3
SEC form 10
2022-10-27 00:00 ET
CONMED Corporation reported for 2022 q3
SEC form 6
2022-10-26 16:24 ET
CONMED Corporation published news for 2022 q3
SEC form 8
2022-10-26 00:00 ET
CONMED Corporation reported for 2022 q3
SEC form 6
2022-08-11 16:23 ET
CONMED Corporation published news for 2022 q2
SEC form 6
2022-08-09 16:35 ET
CONMED Corporation published news for 2022 q2
SEC form 6
2022-08-01 21:18 ET
CONMED Corporation published news for 2022 q2
SEC form 10
2022-07-28 12:01 ET
CONMED Corporation published news for 2022 q2
SEC form 10
2022-07-28 00:00 ET
CONMED Corporation reported for 2022 q2
SEC form 6
2022-07-27 16:16 ET
CONMED Corporation published news for 2022 q2
SEC form 8
2022-07-27 00:00 ET
CONMED Corporation reported for 2022 q2
SEC form 6
2022-06-21 14:44 ET
CONMED Corporation published news for 2022 q1
SEC form 6
2022-06-13 16:36 ET
CONMED Corporation published news for 2022 q1
SEC form 6
2022-06-07 16:48 ET
CONMED Corporation published news for 2022 q1
SEC form 6
2022-06-02 08:03 ET
CONMED Corporation published news for 2022 q1
SEC form 6
2022-05-31 16:30 ET
CONMED Corporation published news for 2022 q1
SEC form 6
2022-05-25 18:46 ET
CONMED Corporation published news for 2022 q1
SEC form 10
2022-05-05 10:13 ET
CONMED Corporation published news for 2022 q1
SEC form 6
2022-05-05 06:31 ET
CONMED Corporation published news for 2022 q1
SEC form 10
2022-05-05 00:00 ET
CONMED Corporation reported for 2022 q1
SEC form 6
2022-05-04 16:26 ET
CONMED Corporation published news for 2022 q1
SEC form 8
2022-05-04 00:00 ET
CONMED Corporation reported for 2022 q1
SEC form 6
2022-04-15 07:45 ET
CONMED Corporation published news for 2022 q1
SEC form 6
2022-04-08 16:36 ET
CONMED Corporation published news for 2022 q1
SEC form 6
2022-03-07 08:57 ET
CONMED Corporation published news for 2021 q4
SEC form 6
2022-02-28 16:34 ET
CONMED Corporation published news for 2021 q4
SEC form 10
2022-02-22 08:37 ET
CONMED Corporation published news for 2021 q4
SEC form 10
2022-02-22 00:00 ET
CONMED Corporation published news for 2021 q4
SEC form 6
2022-01-26 17:05 ET
CONMED Corporation reported for 2021 q4
SEC form 8
2022-01-26 00:00 ET
CONMED Corporation published news for 2021 q4
SEC form 6
2021-11-29 16:58 ET
CONMED Corporation published news for 2021 q3
SEC form 10
2021-10-28 09:57 ET
CONMED Corporation published news for 2021 q3
SEC form 10
2021-10-28 00:00 ET
CONMED Corporation published news for 2021 q3
SEC form 6
2021-10-27 16:30 ET
CONMED Corporation published news for 2021 q3
SEC form 8
2021-10-27 00:00 ET
CONMED Corporation published news for 2021 q3
SEC form 6
2021-08-12 16:26 ET
CONMED Corporation published news for 2021 q2
SEC form 10
2021-07-29 09:33 ET
CONMED Corporation published news for 2021 q2
SEC form 10
2021-07-29 00:00 ET
CONMED Corporation published news for 2021 q2
SEC form 6
2021-07-28 16:27 ET
CONMED Corporation published news for 2021 q2
SEC form 8
2021-07-28 00:00 ET
CONMED Corporation published news for 2021 q2
SEC form 6
2021-07-16 16:16 ET
CONMED Corporation published news for 2021 q2
SEC form 6
2021-07-09 14:42 ET
CONMED Corporation published news for 2021 q2
SEC form 6
2021-06-17 18:00 ET
CONMED Corporation published news for 2021 q1
SEC form 6
2021-05-20 16:05 ET
CONMED Corporation published news for 2021 q1
SEC form 10
2021-04-29 10:16 ET
CONMED Corporation published news for 2021 q1
SEC form 10
2021-04-29 00:00 ET
CONMED Corporation published news for 2021 q1
SEC form 6
2021-04-28 16:38 ET
CONMED Corporation published news for 2021 q1
SEC form 8
2021-04-28 00:00 ET
CONMED Corporation published news for 2021 q1
SEC form 6
2021-04-19 16:15 ET
CONMED Corporation published news for 2021 q1
SEC form 6
2021-04-09 12:53 ET
CONMED Corporation published news for 2021 q1
SEC form 6
2021-02-23 16:44 ET
CONMED Corporation published news for 2020 q4
SEC form 10
2021-02-22 13:28 ET
CONMED Corporation published news for 2020 q4
SEC form 6
2021-01-27 16:34 ET
CONMED Corporation published news for 2020 q4
SEC form 6
2020-11-23 06:50 ET
CONMED Corporation published news for 2020 q3
SEC form 6
2020-11-13 16:52 ET
CONMED Corporation published news for 2020 q3
SEC form 10
2020-10-29 09:41 ET
CONMED Corporation published news for 2020 q3
SEC form 6
2020-10-28 16:37 ET
CONMED Corporation published news for 2020 q3
SEC form 6
2020-10-01 08:01 ET
CONMED Corporation published news for 2020 q3